about
"Identifying the hospitalised patient in crisis"--a consensus conference on the afferent limb of rapid response systems.Recommendations for ulcer prophylaxis in the treatment of patients with severe sepsis and septic shock: a dog chasing its tail?Intensive care medicine: finding its way in the "European labyrinth".Prevalence and factors of intensive care unit conflicts: the conflicus study.Second International Conference on Rapid Response System and Medical Emergency Team, 28-30 June 2006, Pittsburgh, PA, USA.Rapid response teams improve outcomes: yes.Inappropriate care in European ICUs: confronting views from nurses and junior and senior physicians.Best practice for sepsis.DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?Patients' and surrogates' perspective on research and testing in critical careA novel method of treating hypoxemia during one-lung ventilation for thoracic surgeryOutcomes in severe sepsis and patients with septic shock do not matter! PIRO is a score to treat severe septic and septic shock patients not to measure outcomesPIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumoniaNight shifts, human factors, and errors in the ICU: a causal pathway?Factors associated with success in the oral part of the European Diploma in Intensive Care"Judge a Man by His Questions Rather Than by His Answers" Voltaire
P50
Q34098237-56C16501-D412-420B-9AE7-D1BAA4D810D2Q36745460-8830279D-E50C-46CA-BB37-859FA67616EDQ39690397-2D74AB98-CB68-47F0-ACB0-BAB9D9FD647EQ39958938-56D12E12-566A-4A14-BA26-2172EE5415FDQ43055032-94572756-2BE3-48A3-AD05-C35911F70F8BQ47594081-B7698132-18D0-4047-B966-8A97C05AA1F5Q49069800-6A973441-34B3-455D-BE55-FD0F454B83A2Q55317325-FDB61345-BA5C-4C5F-BCDA-886AF46D80A0Q57237700-0AED14A0-0F24-4321-9F14-08FA5E31C335Q79467258-30443FB3-D6FD-4ABD-9979-142F1A0735F5Q82047444-BD862B1A-D03E-4112-B403-AEE54536AE97Q83253702-B9E22AF3-24D6-41E7-A2F0-6FDEAB55853BQ83901630-EAA876AB-D29B-47A7-ABF8-6C738C2A4E1EQ86867776-87C7881A-CA23-47FD-8ADE-9F38C9D5BE7EQ89204597-D4066FC9-6A61-43C7-88D8-4A82CE5DBDB7Q89878611-845C9B67-6B62-4EAD-BB01-BEAB1426EEFC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesca Rubulotta
@ast
Francesca Rubulotta
@en
Francesca Rubulotta
@es
Francesca Rubulotta
@nl
type
label
Francesca Rubulotta
@ast
Francesca Rubulotta
@en
Francesca Rubulotta
@es
Francesca Rubulotta
@nl
prefLabel
Francesca Rubulotta
@ast
Francesca Rubulotta
@en
Francesca Rubulotta
@es
Francesca Rubulotta
@nl
P106
P1153
55999703900
P31
P496
0000-0001-8644-1728